Search

Your search keyword '"Lichtman, Judith H."' showing total 3 results
Start Over Author "Lichtman, Judith H." Journal american journal of medicine
3 results on '"Lichtman, Judith H."'

1. Acute, severe noncardiac conditions in patients with acute myocardial infarction

Author

Lichtman, Judith H., Fathi, Amir, Radford, Martha J., Lin, Zhenqiu, Loeser, Caroline S., and Krumholz, Harlan M.

Subjects
Heart attack -- Risk factors, Heart attack -- Prognosis, Heart attack -- Care and treatment, Health, Health care industry
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2006.03.040 Byline: Judith H. Lichtman (a), Amir Fathi (b), Martha J. Radford (c), Zhenqiu Lin (d), Caroline S. Loeser (e), Harlan M. Krumholz (d)(f)(g)(h) Keywords: Acute myocardial infarction; Mortality; Risk factors Abstract: The study's purpose was to determine the prevalence and prognostic importance of acute, severe, noncardiac conditions present at the time of an acute myocardial infarction (AMI). Author Affiliation: (a) Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn (b) Department of Medicine, Massachusetts General Hospital, Boston, Mass (c) Division of Cardiology, Department of Medicine, New York University Medical Center, New York, NY (d) Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn (e) Department of Medicine, Yale University School of Medicine, New Haven, Conn (f) Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn (g) Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Conn (h) Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Conn. Article History: Revised 20 March 2006 Article Note: (footnote) Dr. Lichtman is supported by grant number 1 K01 DP000085-01 from the Centers for Disease Control and Prevention (CDC). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of CDC.

Published
2006

2. National Trends in Outcomes Among Elderly Patients with Heart Failure

Author

Kosiborod, Mikhail, Lichtman, Judith H., Heidenreich, Paul A., Normand, Sharon-Lise T., Wang, Yun, Brass, Lawrence M., and Krumholz, Harlan M.

Subjects
Heart failure -- Complications and side effects, Heart failure -- Care and treatment, Aged patients -- Health aspects, Mortality -- United States, Mortality -- Research, Health, Health care industry
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2005.11.019 Byline: Mikhail Kosiborod (a), Judith H. Lichtman (b), Paul A. Heidenreich (c), Sharon-Lise T. Normand (d), Yun Wang (e), Lawrence M. Brass (b)(f)(g), Harlan M. Krumholz (e)(h)(i)(j) Keywords: Heart failure; Health services research; Trends Abstract: Despite dramatic changes in heart failure management during the 1990s, little is known about the national heart failure mortality trends during this time period, particularly among the elderly. The purpose of this study was to determine temporal trends in outcomes of elderly patients with heart failure between 1992 and 1999. Author Affiliation: (a) Mid America Heart Institute of Saint Luke's Hospital and the University of Missouri, Kansas City, Mo (b) Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn (c) VA Palo Alto Health Care System, and the Department of Medicine, Stanford University, Stanford, Calif (d) Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Harvard School of Public Health, Boston, Mass (e) Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn (f) Department of Neurology, Yale University School of Medicine, New Haven, Conn (g) Neurology Service of the VA Connecticut Healthcare System, West Haven, Conn (h) Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn (i) Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Conn (j) Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Conn. Article Note: (footnote) This publication was supported by grant number 1 K01 DP000085-01 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. The Centers for Medicare and Medicaid Services (CMS) reviewed and approved the use of its data for this work, and approved submission of the manuscript; this approval is based on data use only, and does not represent a CMS endorsement of or comment on the manuscript content. Neither CDC nor CMS played a role in the design and conduct of the study, or in the analysis and interpretation of the data. All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the analysis.

Published
2006

3. Delay in Presentation and Reperfusion Therapy in ST-Elevation Myocardial Infarction

Author

Ting, Henry H., Bradley, Elizabeth H., Wang, Yongfei, Nallamothu, Brahmajee K., Gersh, Bernard J., Roger, Veronique L., Lichtman, Judith H., Curtis, Jeptha P., and Krumholz, Harlan M.

Subjects
*TREATMENT of reperfusion injuries, *MYOCARDIAL infarction, *RANDOMIZED controlled trials, *SYMPTOMS, *MYOCARDIAL infarction treatment, *COMPARATIVE studies, *ELECTROCARDIOGRAPHY, *EMERGENCY medical services, *HOSPITAL emergency services, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *MULTIVARIATE analysis, *MYOCARDIAL revascularization, *PROBABILITY theory, *RESEARCH, *SURVIVAL analysis (Biometry), *THROMBOLYTIC therapy, *TIME, *TRANSLUMINAL angioplasty, *EVALUATION research, *TREATMENT effectiveness, *ACQUISITION of data, *RETROSPECTIVE studies, *EARLY diagnosis, *HOSPITAL mortality, *ODDS ratio, MYOCARDIAL infarction diagnosis, MYOCARDIAL infarction-related mortality
Abstract

Abstract: Background: We studied the relationship between longer delays from symptom onset to hospital presentation and the use of any reperfusion therapy, door-to-balloon time, and door-to-drug time. Methods: Cohort study of patients with ST-elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from January 1, 1995 to December 31, 2004. Delay in hospital presentation was categorized into 1-hour intervals as ≤1 hour, >1-2 hours, >2-3 hours, etc, up to >11-12 hours. The study analyzed 3 groups: 440,398 patients for the association between delay and use of any reperfusion therapy; 67,207 patients for the association between delay and door-to-balloon time; 183,441 patients for the association between delay and door-to-drug time. Results: In adjusted analyses, patients with longer delays between symptom onset and hospital presentation were less likely to receive any reperfusion therapy, had longer door-to-balloon times, and had longer door-to-needle times (all P <.0001 for linear trend). For patients presenting ≤1 hour, >1-2 hours, >2-3 hours, >9-10 hours, >10-11 hours, and >11-12 hours after symptom onset, the use of any reperfusion therapy were 77%, 77%, 73%, 53%, 50%, and 46%, respectively. Door-to-balloon times were 99, 101, 106, 123, 125, and 123 minutes, respectively, and door-to-drug times were 33, 34, 36, 46, 44, and 47 minutes, respectively. Conclusions: Longer delays from symptom onset to hospital presentation were associated with reduced likelihood of receiving primary reperfusion therapy, and even among those treated, late presenters had significantly longer door-to-balloon and door-to-drug times. [Copyright &y& Elsevier]

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results